EBV-TCR-T Cell therapy (Pla General Hospital)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameEBV-TCR-T Cell therapy (Pla General Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLymphoproliferative DisordersEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPla General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPla General Hospital
Inactive CompaniesN/A
Active IndicationsLymphoproliferative DisordersEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A